1395950-84-1 (Crizotinib-d5 (PF-02341066),Crizotinib-d)

克里唑蒂尼-D5;(R)-CRIZOTINIB-D5(哌啶-3,3,4,5,5-D5);克唑替尼-[D5];2H5]-(R)-克唑替尼;克唑替尼-D5(克唑替尼杂质1);克唑替尼 d5;

Crizotinib-d5;Crizotinib-d5 (PF-02341066);(R)-Crizotinib-d5 (piperidine-3,3,4,5,5-d5);(R)-Crizotinib-d5;2H5]-(R)-Crizotinib;Crizotinib-d;2-Pyridinamine, 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl-3,3,4,5,5-d5)-1H-pyrazol-4-yl]- (ACI); 3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl-3,3,4,5,5-d5)-1H-pyrazol-4-yl]-2-pyridinamine (ACI);1395950-84-1;F90677;CS-0090323;3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(3,3,4,5,5-pentadeuteriopiperidin-4-yl)pyrazol-4-yl]pyridin-2-amine;HY-50878S;

KTEIFNKAUNYNJU-GFCCVEGCSA-N

1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1

O(C1C(=NC=C(C2C=NN(C3([H])C([H])([H])CNCC3([H])[H])C=2)C=1)N)[C@@H](C1C(=CC=C(F)C=1Cl)Cl)C